The market was valued at USD 11 billion in 2017 and is projected to reach USD 51 billion by 2022, at a CAGR of 29% during the forecast period. The increasing prevalence of chronic diseases such as cancer and HIV/AIDS are the major reasons driving the market growth. These medicines helps to strengthen the immune response of the body against specific diseases. However every medicine need to be approved by FDA. Increasing cases of chronic diseases and need for effective treatment is acting as key driver for this market. Various pharmaceutical companies are working to develop novel vaccines for diseases such as lung cancer, breast cancer, Alzheimer, etc. However, these vaccine developments are in pipeline and yet to be commercialized.
Download free Sample of This Strategic Report:
Some of the factors that are propelling the growth of the market arethe favorable funding for R&D, increasing investments by companies, and rise in the prevalence of chronic diseases are. However, high costs of the vaccines and stringent regulatory guidelines are turning out to be hurdles for this market. Provenge and Oncophage are the two approved cancer therapeutic vaccines on the market. A large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.
The market can be segmented by type and geography.
Segmentation by Type –
Auto Immune Diseases Vaccines
Neurological Disease Vaccines
Infectious Diseases Vaccines
The cancer vaccines sub-segment contributes the highest share in the market.
Segmentation by Geography –
The Middle East and Africa
North America has the largest market size, followed by Europe.Rising population and large investments in the field of research and development are few of the reasons for the advancement of the market in Asia-Pacific.
Segmentation by technologies:
The Key players in the therapeutic vaccines market are:
Bavarian Nordic, Dendreon Corp, GlaxoSmithKline, Pfizer,Cytos Biotechnology, Merck Serono, Novartis, Celtic Pharmaand Transgene
Report ContentsRegional AnalysisReport Highlights
Market Drivers, Restraints and Opportunities
Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Market – Current Trends
Competition & Major Companies
Technology and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
US and Canada
Mexico, Brazil, Argentina and Rest of Latin America
EU5 (Germany, France, Italy, Spain, U.K.)
Nordic Countries (Denmark, Finland, Norway, and Sweden)
Benelux (Belgium, The Netherlands, and Luxembourg)
Rest of Western Europe
Rest of Eastern Europe
Request For Full Report: https://www.kennethresearch.com/report-details/global-therapeutic-vaccines-market/10065102
Australia and New Zealand
Rest of Asia Pacific
Middle East and Africa
GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
Rest of Middle East and Africa
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation.
Phone:+1 313 462 0609